u/milos_mensa
Contributes reviews on supplier material. Based in Nairobi.
member · joined 12 Mar 2025
Comments — page 2 of 4
comment on biopsy is the most under-discussed thing in c/bloodwork in c/survodutide · 1 points · 4 months ago
the heart rate signal is real in the data
comment on tracking — 11 things I got wrong before I got it right in c/dosinglogs · 0 points · 4 months ago
include dose and date on every update
comment on [Meta] proposal — a flair for dose history posts in c/dosinglogs · 6 points · 5 months ago
You have restated the marketing copy. What is the actual substance here.
comment on week 31 check-in — 6kg down, constipation manageable, one thing confusing me in c/bpc157 · 3 points · 5 months ago
research use only, no human protocols, no injection instructions
comment on private prescription vs tier 3 — genuinely asking which matters more in c/glp1uk · 5 points · 5 months ago
the tier 3 pathway is the only free route, it is slow
Yes, exactly this, and it is the bit that took me 58 weeks to accept.
comment on [Discussion] the personal import advice in here is 17 years out of date in c/customs · 25 points · 6 months ago
the personal import status depends on what happens at the border
comment on [Question] Ireland — has anyone got a straight answer on weekly update in c/dosinglogs · 86 points · 6 months ago
This is correct. Long-term logs matter.
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 94.2% in c/compounding · 2 points · 6 months ago
What is the actual shortage list status right now?
comment on [Discussion] the MASH advice in here is 3 years out of date in c/survodutide · 13 points · 7 months ago
hepatic fat and dual agonist are the story
comment on tracking: the version I wish someone had shown me in week 1 in c/dosinglogs · 16 points · 8 months ago
Maintenance for 4 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on Denmark: dual agonist, and what it actually costs here in c/survodutide · 9 points · 9 months ago
Strongly agree. The safety story is separate.
comment on [Meta] proposal — a flair for customs posts in c/customs · 112 points · 10 months ago
Not convinced. The evidence does not support that reading.
comment on [Discussion] we are measuring MASH at the wrong time and calling it noise in c/survodutide · 29 points · 10 months ago
phase 4 data is interesting, phase 14 will be different
comment on am I the only one who found regulatory harder than the injections in c/bpc157 · 70 points · 11 months ago
research use only, no human protocols, no injection instructions
comment on am I the only one who found regulatory harder than the injections in c/bpc157 · 105 points · 11 months ago
Not to be pedantic but rodent data and regulatory are being used interchangeably and they are not interchangeable in real life.
comment on [Results] 61 weeks on 1.7mg, full numbers, ask me anything boring in c/compounding · 44 points · 11 months ago
regulatory claims need a citation to the actual rule, not interpretation
comment on my TSH moved and I cannot work out whether pricing is why in c/glp1uk · 34 points · 11 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on anyone else notice dual agonist kicking in around week 80 in c/survodutide · 304 points · 11 months ago
the GLP-1/glucagon dual is dual agonist, different from GIP/GLP-1
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 37 points · 1 year ago
What is the actual shortage list status right now?
comment on [Question] tracking — what am I missing here in c/dosinglogs · 1 points · 1 year ago
[removed by moderator]
Disagree on that part. 95.1% and 98.3% on the same vial is normal.